AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπ²
Rosuvastatin in Zambia
6 products registered with ZAMRA β 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Turbovas 10 Tablets Tablet Uncoated | 315/038 | MICRO LABS LTD | active | 14 Jun 2031 |
| DISMIGRAS 40 Tablet, Filmcoated | ZAMRA-HM-25-337 | MSN Laboratories Private Limited | active | 4 Oct 2030 |
| Rovas 20 Tablets Tablets+ Filmcoated | 085/058 | Intas Pharmaceuticals Limited | active | 10 Jul 2030 |
| Rosta 10 Tablets | 446/006 | Glenmark Pharmaceuticals Ltd | active | 1 Oct 2026 |
| Rosta 20 Tablets | 446/007 | Glenmark Pharmaceuticals Ltd | active | 1 Oct 2026 |
| Turbovas 20 Tablets | 315/039 | MICRO LABS LTD | active | 23 Jun 2026 |
Rosuvastatin β ZAMRA Registration Details
ZAMRA (Zambia) has 6 registered products containing Rosuvastatin, of which 6 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Rosuvastatin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.